BMTCN solution pack correctly answered to pass 2023

BMTCN question & answers 2023 graded A+ already passed What type of transplants commonly have PTLD as a secondary malignancy? - correct answer Allo HSCT with T-cell depleted graft Therapies associated with therapy-related acute leukemia and MDS - correct answer alkylating agents (eg. Cytoxan, cis...

BMTCN Free Test correctly answered 100% graded A+ Which of the following studies should be completed at regular intervals for a patient receiving long-term steroids? A. Positron emission tomography scan B. Magnetic resonance imaging C. Dual energy x-ray absorptiometry D. Computed tomography s...

BMTCN Test C question and answers rated A+ 2023 updatedMyeloid progenitors give rise to which of the following types of cells during hematopoiesis? A. NK cells B. Plasma Cells C. Erythrocytes D. T lymphocytes - correct answer D. T lymphocytes Myeloid progenitors give rise to erythrocytes ...

BMTCN Test B question with complete solution 2023 Transplant-related toxicity is a barrier that contributes to the under utilization for which of the following diseases? A. Non-Hodgkin lymphoma B. Acute myeloid leukemia C. Sickle cell disease D. Neuroblastoma - correct answer C. Sickle cell...

BMTCN Chapter 5: Graft-versus-Host Disease fully solved 2023 T.R. is a 28-year-old woman with acute myeloid leukemia in her second complete remission who is admitted for a matched unrelated allogeneic stem cell transplantation. Her conditioning regimen is as follows: Myeloablation (busulfan/cycl...

BMTCN Chapter 1: Basic Concepts and Indications for Transplantation correctly answered graded A+Which of the following is an example of a myeloid cell? A. Thymus-derived cells (T cells) B. Bone marrow-derived cells (B cells) C. Monocytes D. Natural killer cells - correct answer C. Monocytes S...

BMTCN Free Test question with 100% correct answers 2023Which of the following studies should be completed at regular intervals for a patient receiving long-term steroids? A. Positron emission tomography scan B. Magnetic resonance imaging C. Dual energy x-ray absorptiometry D. Computed tomograp...

BMTCN Ch 5 – GVHD question with correct solution graded A+ PASSEDoverall incidence of GVH? - correct answer 20-80% mortality rates d/t GVH? matched sibling vs unrelated - correct answer 18 % matched ib 20% unrelated what is GVH? - correct answer T cells from the donor recognize the recipien...

BMTCN Chapter 4: Transplant Preparative Regimens, Cellular Infusion, Acute Complications, and Engraftment 2023 verifiedWhat is the most important rationale for giving total body irradiation in multiple fractions? A. It is easier for patients. B. It decreases short-term side effects. C. It decreas...

BMTCN Chapter 7: Survivorship Issues question with complete solution 2023 What is a patient who received a T-cell-depleted transplant at risk for developing within the first year following transplant? A. Acute myeloid leukemia B. Breast cancer C. Basal cell carcinoma D. Post-transplant lympho...

BMTCN Chapter 6: Post-Transplant Issues question with complete solution 2023Which of the following is NOT an identified risk factor associated with infection? A. Personal history of infection B. Type of transplantation (autologous or allogeneic) C. Myeloablative transplant D. None of the abo...

Top 10 Interview Q's (UCH) question and answers 2023 graded A+Professional goal - correct answer oncology certified nurse (OCN), blood & marrow transplant certified nurse (BMTCN), certified translator -consists of various steps: being accepted into nursing school (via INP), graduating nursing scho...

BMTCN Study question and answers 2023 graded A+ already passedMyeloid - correct answer erythrocyte, platelets, neutrophil, basophil, eosinophil, monoblast, macrophage, monocyte lymphoid - correct answer pre- B cell, pre-t cell, plasma cell, natural killer cell, t lymphocyte innate immunity - c...

BMTCN Practice Test A question and answers latest update 2023Which of the following medications should a patient taking cyclosporine avoid following an allogenic HSCT? A. Torsemide B. Bumetanide C. Spironolactone D. Furosemide - correct answer C. Patients taking cyclosporine should avoid potassi...